Self-copying RNA vaccine wins first full approval: what’s next?

Elie Dolgin

Nature, 2023, vol. 624, issue 7991, 236-237

Abstract: Researchers look ahead to the potential uses and benefits of a technology that has been more than 20 years in the making.

Keywords: Vaccines; SARS-CoV-2 (search for similar items in EconPapers)
Date: 2023
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/d41586-023-03859-w Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:624:y:2023:i:7991:d:10.1038_d41586-023-03859-w

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-023-03859-w

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().